Shanghai Pharmaceuticals (SHPMF) Stock Price, News & Analysis

Company Overview

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based pharmaceutical and healthcare company engaged in the research, development, manufacture, distribution and retail sale of medicines and healthcare products. Its product portfolio includes prescription drugs, over-the-counter medicines, traditional Chinese medicines and other pharmaceutical products used in areas such as cardiovascular care, infectious diseases, oncology and central nervous system disorders.

The company operates pharmaceutical manufacturing facilities and sells products through hospitals, pharmacies and other healthcare channels. It also provides pharmaceutical distribution and supply-chain services, helping deliver medicines and medical products to healthcare institutions and retail customers. Its retail operations include pharmacy businesses serving consumers in China.

Shanghai Pharmaceuticals primarily serves the Chinese healthcare market and has developed international activities through product sales, partnerships and other overseas operations. The company is headquartered in Shanghai and is listed on the Shanghai and Hong Kong stock exchanges. Its shares also trade in the United States over the counter under the symbol SHPMF.

Key Stats

• Today's Range: $1.39 to $1.41
• 50-Day Range: $1.41 to $1.46
• 52-Week Range: $1.46 to $1.53
• Volume: N/A
• Average Volume: 33,943 shs
• Market Capitalization: N/A
• P/E Ratio: 1.51
• Dividend Yield: 18.70%
• Price Target: N/A
• Consensus Rating: N/A

Shanghai Pharmaceuticals Stock Analysis - MarketRank™

Shanghai Pharmaceuticals scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Shanghai Pharmaceuticals.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Shanghai Pharmaceuticals is 1.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.84.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shanghai Pharmaceuticals is 1.51, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.90.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Shanghai Pharmaceuticals has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shanghai Pharmaceuticals has recently increased by 28.33%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Shanghai Pharmaceuticals pays a meaningful dividend of 2.01%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Shanghai Pharmaceuticals does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Shanghai Pharmaceuticals is 28.26%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Shanghai Pharmaceuticals this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Shanghai Pharmaceuticals insiders have not sold or bought any company stock.

Percentage Held by Institutions

6.84% of the stock of Shanghai Pharmaceuticals is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHPMF
• CIK: 1570300
• Web: www.sphchina.com
• Phone: 86-21-6373-0908
• Fax: N/A
• Employees: 49,234
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.51
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A